Shawn Cross

Shawn Cross

Director/Board Member presso BIOPLUS ACQUISITION CORP.

Patrimonio netto: 100 922 $ in data 31/03/2024

56 anni
Finance
Health Technology
Consumer Services

Profilo

Shawn Mikael Cross is an Independent Director at Cyclo Therapeutics, Inc. and BioPlus Acquisition Corp.
He previously served as the Chairman & Chief Executive Officer at GT Biopharma, Inc., Applied Molecular Transport, Inc., and Managing Director at Citizens JMP Securities LLC and Wells Fargo Securities LLC.
He also held positions as Principal at Deutsche Bank Securities, Inc., Deutsche Bank AG, Thomas Weisel Partners LLC, Alex.
Brown & Sons, Inc., and the University of Washington Medical Center.
Mr. Cross completed his undergraduate degree at the University of California, Los Angeles and holds an MBA from Columbia Business School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
27/12/2023 72 606 ( 0.25% ) 100 922 $ 31/03/2024

Posizioni attive di Shawn Cross

SocietàPosizioneInizio
BIOPLUS ACQUISITION CORP. Director/Board Member 01/12/2021
CYCLO THERAPEUTICS, INC. Director/Board Member 27/12/2023
Tutte le posizioni attive di Shawn Cross

Precedenti posizioni note di Shawn Cross

SocietàPosizioneFine
APPLIED MOLECULAR TRANSPORT INC. Chief Executive Officer 27/12/2023
Analyst-Equity 01/03/2020
GT BIOPHARMA, INC. Chief Executive Officer 02/07/2018
Corporate Officer/Principal 01/11/2015
Alex. Brown & Sons, Inc. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Shawn Cross

Formazione di Shawn Cross

University of California, Los Angeles Undergraduate Degree
Columbia Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Shawn Cross

Relazioni

100 +

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
GT BIOPHARMA, INC.

Health Technology

CYCLO THERAPEUTICS, INC.

Health Technology

APPLIED MOLECULAR TRANSPORT INC.

Health Technology

Aziende private7

Finance

Finance

Finance

Finance

Alex. Brown & Sons, Inc.

Finance

Finance

Finance

Vedi le connessioni aziendali